HSP27/IL-6 axis promotes OSCC chemoresistance, invasion and migration by orchestrating macrophages via a positive

Ying Qi1, Juan Cao1, Mingjing Jiang1

  • 1Department of Oral Anatomy and Physiology, Hospital of Stomatology, Jilin Provincial Key Laboratory of Oral Biomedical Engineering, Jilin University, Changchun, 130021, China.

PubMed

Insights

The HSP27/IL-6 axis fuels oral cancer progression by promoting chemoresistance and invasion. Targeting this axis offers a promising therapeutic strategy for oral squamous cell carcinoma (OSCC) patients.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) play a critical role in cancer progression.
  • The specific molecular mechanisms driving oral squamous cell carcinoma (OSCC) progression via TAM interactions remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism of the HSP27/IL-6 axis in OSCC chemoresistance, invasion, and migration.
  • To investigate the crosstalk between OSCC cells and TAMs mediated by HSP27 and IL-6.

Main Methods:

  • Demonstrated higher HSP27 expression in OSCC cells.
  • Investigated the role of paracrine HSP27 in inducing M2 polarization and IL-6 secretion in TAMs.
  • Analyzed the positive feedback loop between OSCC cells and M2 TAMs involving HSP27 and IL-6.

Main Results:

  • Paracrine HSP27 from OSCC cells enhanced chemoresistance, invasion, migration, and epithelial-mesenchymal transition (EMT) by promoting M2 TAM polarization and IL-6 secretion.
  • A positive feedback loop between HSP27 and IL-6 was established between OSCC cells and M2 TAMs.
  • TAM-derived IL-6 promoted OSCC stemness and chemoresistance via β-catenin and CD44, and enhanced invasion, migration, and EMT through autocrine HSP27/TLR4 signaling.

Conclusions:

  • The HSP27/IL-6 axis facilitates OSCC chemoresistance, invasion, and migration by orchestrating macrophages via a positive feedback loop.
  • Targeting the HSP27/IL-6 axis presents a potential therapeutic strategy for OSCC, aiming to control disease progression and improve patient outcomes.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
942